Evidence map›Paper›PMID 40498328›Full record

ArticleClinical and experimental medicine2025

28-day all-cause mortality in patients with alcoholic cirrhosis: a machine learning prediction model based on the MIMIC-IV.

Chuang Lei, Zhixiang Ding, Qinghai Wang, Shanqing Tao, Qin Zhou, Pengfei Yin, Yanhong Luo, Fan Yang, Xingtong Chen, Yang Cai and 3 more

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chuang Lei *Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Zhixiang Ding *Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Qinghai Wang *Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Shanqing Tao *Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Qin Zhou *Intensive Care Unit, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Pengfei Yin *Department of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Yanhong LuoDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Fan YangDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Xingtong ChenDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Yang CaiDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Hainan GongDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China.
Dehui LiDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China. lidehui0736@163.com.
Hao LiDepartment of Infectious Diseases, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China. 13721056589@163.com.

Funding

Hunan Provincial Natural Science Foundation Of China 2025JJ70698The science and technology innovation Program of Changde city ckh20225105
6 · The paper itself

Abstract

To develop and validate a machine learning prediction model for 28-day all-cause mortality in patients with alcoholic cirrhosis using data from the MIMIC-IV database. The data of 2134 patients diagnosed with alcoholic cirrhosis (AC) were obtained from Medical Information Mart for Intensive Care IV database. Machine learning algorithms, including decision trees, random forests, extreme gradient boosting, Logistic Regression and support vector machines were employed to develop the prediction model. The model was trained on 70% of the data and validated on the remaining 30% randomly. Performance was assessed using the area under the receiver operating characteristic curve, calibration curves and decision curve analysis (DCA). SHAP analysis was used to assess the marginal effects of each independent variable. The mean age was 56.2 years, and 69.5% were male. The primary factors associated with 28-day mortality included Age, SOFA score, ASPIII score, OASIS score, LODS score, Temperature, Chloride, Lactate, Total bilirubin (Tbil), international normalized ratio (INR), Activated partial thromboplastin time (Aptt), Stroke, Malignancy, Congenital coagulation defect (Ccd). The machine learning model demonstrated good predictive performance in the training and validation group, higher than traditional MELD score. Our machine learning prediction model effectively identifies patients with alcoholic cirrhosis at high risk of 28-day mortality. This model could assist clinicians in early risk stratification and guide clinical decision-making. Further validation in external cohorts is warranted to confirm its generalizability.

Indexed as

Liver Cirrhosis, AlcoholicMachine LearningAdultAgedFemaleHumansMaleMiddle AgedRisk FactorsROC CurveAlcoholic cirrhosisMachine learningMELDMimic-IV

Identifiers

PMID40498328
PMCPMC12159089

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.